Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.680
-0.580 (-11.03%)
At close: Apr 28, 2026, 4:00 PM EDT
4.750
+0.070 (1.50%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $54.42 million as of April 28, 2026. Its market cap has increased by 294.58% in one year.
Market Cap
54.42M
Enterprise Value
52.26M
1-Year Change
294.58%
Ranking
Category
Stock Price
$4.68
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $54.42M, a decrease of -15.34%. That is a compound annual growth rate of -3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 61.17M | 108.58% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 67.58M |
| MediciNova | 67.43M |
| Annovis Bio | 65.27M |
| ImageneBio | 65.21M |
| BeyondSpring | 64.15M |
| iBio, Inc. | 61.81M |
| Cue Biopharma | 58.37M |
| MindWalk Holdings | 57.61M |